UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

BMJ, 2006-11, Vol.333 (7578), p.1091-1094

International edition, 2006

Volltextzugriff (PDF)

Impact of Chronic Constipation on Health-Related Quality of Life, Work Productivity, and Healthcare Resource Use: An Analysis of the National Health and Wellness Survey

Digestive diseases and sciences, 2011-09, Vol.56 (9), p.2688-2695

2011

Volltextzugriff (PDF)

Hyperuricemia and the risk for subclinical coronary atherosclerosis--data from a prospective observational cohort study

Arthritis research & therapy, 2011-04, Vol.13 (2), p.R66-R66, Article R66

2011

Volltextzugriff (PDF)

A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry

JAMA : the journal of the American Medical Association, 2004-06, Vol.291 (22), p.2727

2004

Volltextzugriff (PDF)

Real-world evidence for coverage determination of treatments for rare diseases

Orphanet journal of rare diseases, 2024-02, Vol.19 (1), p.47-47, Article 47

2024

Volltextzugriff (PDF)

Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients

Journal of market access & health policy, 2019, Vol.7 (1), p.1601484-1601484

2019

Volltextzugriff (PDF)

Determinants and prognostic impact of heart failure complicating Acute Coronary Syndromes: Observations from the Global Registry of Acute Coronary Events (GRACE)

Circulation (New York, N.Y.), 2004-02, Vol.109 (4), p.494-499

2004

Volltextzugriff (PDF)

Economic burden of spinal muscular atrophy: an analysis of claims data

Journal of market access & health policy, 2020, Vol.8 (1), p.1843277

2020

Volltextzugriff (PDF)

An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER)

Journal of market access & health policy, 2021, Vol.9 (1), p.1889841-1889841

2021

Volltextzugriff (PDF)

In-Hospital Revascularization and One-Year Outcome of Acute Coronary Syndrome Patients Stratified by the GRACE Risk Score

The American journal of cardiology, 2005-10, Vol.96 (7), p.913-916

2005

Volltextzugriff (PDF)

From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes: The Global Registry of Acute Coronary Events (GRACE)

European heart journal, 2003-08, Vol.24 (15), p.1414-1424

2003

Volltextzugriff (PDF)

Medication performance measures and mortality following acute coronary syndromes

The American journal of medicine, 2005-08, Vol.118 (8), p.858-865

2005

Volltextzugriff (PDF)

Health economic evaluation of gene replacement therapies: methodological issues and recommendations

Journal of market access & health policy, 2020, Vol.8 (1), p.1822666

2020

Volltextzugriff (PDF)

Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation

The American journal of cardiology, 2003-11, Vol.92 (9), p.1031-1036

2003

Volltextzugriff (PDF)

Circulating Secretory Phospholipase A2 Activity Predicts Recurrent Events in Patients With Severe Acute Coronary Syndromes

Journal of the American College of Cardiology, 2005-10, Vol.46 (7), p.1249-1257

2005

Volltextzugriff (PDF)

Hyperuricemia and the Echocardiographic Measures of Myocardial Dysfunction

Congestive heart failure (Greenwich, Conn.), 2012-05, Vol.18 (3), p.138-143

2012

Volltextzugriff (PDF)

Development and Psychometric Evaluation of 2 Age‐stratified Versions of the Pediatric GERD Symptom and Quality of Life Questionnaire

Journal of pediatric gastroenterology and nutrition, 2011-05, Vol.52 (5), p.514-522

2011

Volltextzugriff (PDF)

Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes : Findings from a global registry of acute coronary events

Circulation (New York, N.Y.), 2005-06, Vol.111 (24), p.3242-3247

2005

Volltextzugriff (PDF)

Hyperuricemia in Young Adults and Risk of Insulin Resistance, Prediabetes, and Diabetes: A 15-Year Follow-up Study

American journal of epidemiology, 2012-07, Vol.176 (2), p.108-116

2012

Volltextzugriff (PDF)

Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)

The American heart journal, 2003-12, Vol.146 (6), p.999-1006

2003

Volltextzugriff (PDF)

Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE)

The American heart journal, 2004-01, Vol.147 (1), p.42-48

2004

Volltextzugriff (PDF)

Chronic kidney disease in gout in a managed care setting

BMC nephrology, 2011-08, Vol.12 (1), p.36-36, Article 36

2011

Volltextzugriff (PDF)

Body of Evidence for Onasemnogene Abeparvovec in Spinal Muscular Atrophy Supports Long-Term Duration of Effect Without Relapse

Value in health, 2022-11, Vol.25 (11), p.1922-1923

2022

Volltextzugriff (PDF)

Matching-adjusted indirect treatment comparison of onasemnogene abeparvovec and nusinersen for the treatment of symptomatic patients with spinal muscular atrophy type 1

Current medical research and opinion, 2021-10, Vol.37 (10), p.1719-1730

2021

Volltextzugriff (PDF)

Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)

The American heart journal, 2007-06, Vol.153 (6), p.960-969

2007

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(125)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

Impact of Chronic Constipation on Health-Related Quality of Life, Work Productivity, and Healthcare Resource Use: An Analysis of the National Health and Wellness Survey

Hyperuricemia and the risk for subclinical coronary atherosclerosis--data from a prospective observational cohort study

A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry

Real-world evidence for coverage determination of treatments for rare diseases

Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients

Determinants and prognostic impact of heart failure complicating Acute Coronary Syndromes: Observations from the Global Registry of Acute Coronary Events (GRACE)

Economic burden of spinal muscular atrophy: an analysis of claims data

An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER)

In-Hospital Revascularization and One-Year Outcome of Acute Coronary Syndrome Patients Stratified by the GRACE Risk Score

From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes: The Global Registry of Acute Coronary Events (GRACE)

Medication performance measures and mortality following acute coronary syndromes

Health economic evaluation of gene replacement therapies: methodological issues and recommendations

Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation

Circulating Secretory Phospholipase A2 Activity Predicts Recurrent Events in Patients With Severe Acute Coronary Syndromes

Hyperuricemia and the Echocardiographic Measures of Myocardial Dysfunction

Development and Psychometric Evaluation of 2 Age‐stratified Versions of the Pediatric GERD Symptom and Quality of Life Questionnaire

Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes : Findings from a global registry of acute coronary events

Hyperuricemia in Young Adults and Risk of Insulin Resistance, Prediabetes, and Diabetes: A 15-Year Follow-up Study

Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)

Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE)

Chronic kidney disease in gout in a managed care setting

Body of Evidence for Onasemnogene Abeparvovec in Spinal Muscular Atrophy Supports Long-Term Duration of Effect Without Relapse

Matching-adjusted indirect treatment comparison of onasemnogene abeparvovec and nusinersen for the treatment of symptomatic patients with spinal muscular atrophy type 1

Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)

Suchergebnisse filtern